Connect with us

Hi, what are you looking for?

Jewish Business News


Insuline Signs J&J Marketing Deal For A Pilot In Germany

Insuline has developed a medical device that increases insulin absorption.


Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Insuline Medical Ltd. (TASE: INSL), developer of a medical device that improves the rate of insulin absorption for diabetics, has finalized a deal with J&J (NYSE:JNJ) unit, LifeScan, Inc. Under the terms of the agreement, LifeScan will market Insuline’s product in Germany.Following the announcement, the company’s share price rose 6.7%, with a trading volume of NIS 10 million ($2.7 mullion) , triple the average amount over the past month. Insuline has a market cap of NIS 314 million ($87 million).

Insuline has developed a medical device that warms the injection site, and increases the rate at which the insulin is absorbed. The faster the insulin is absorbed, the more effective it is. Currently, there are chemically-enhanced, rapid-acting insulin products on the market, but Insuline’s product improves the absorption rates of both rapid-acting insulin, and regular insulin.

The company chose to launch its product first in Germany, where it will serve as a pilot, and a future basis for all European markets.

Published by 



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News